B
ISSUER//CIK 0001103021
BIODELIVERY SCIENCES INTERNATIONAL INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A55.2 KBBIODELIVERY SCIENCES INTERNATIONAL INCFeb 10, 4:14 PM ET·0001172661-23-000628
- 8-K291.8 KBBIODELIVERY SCIENCES INTERNATIONAL INCMar 22, 5:09 PM ET·0001104659-22-036625
- 10-K10.5 MBBIODELIVERY SCIENCES INTERNATIONAL INCMar 9, 5:28 PM ET·0001103021-22-000051
- SC 13D123.5 KBBIODELIVERY SCIENCES INTERNATIONAL INCFeb 24, 12:05 PM ET·0001104659-22-026456
- SC 13G54.9 KBBIODELIVERY SCIENCES INTERNATIONAL INCFeb 24, 11:06 AM ET·0001172661-22-001004
- 8-K/A1.1 MBBIODELIVERY SCIENCES INTERNATIONAL INCFeb 15, 4:54 PM ET·0001104659-22-023843
- 8-K37.6 MBBIODELIVERY SCIENCES INTERNATIONAL INCFeb 14, 8:21 AM ET·0001103021-22-000035
- SC 13G/A48.8 KBBIODELIVERY SCIENCES INTERNATIONAL INCFeb 14, 8:04 AM ET·0001104659-22-021621
- SC 13G/A98.9 KBBIODELIVERY SCIENCES INTERNATIONAL INCFeb 11, 4:11 PM ET·0001193805-22-000245
- SC 13G/A13.5 KBBIODELIVERY SCIENCES INTERNATIONAL INCFeb 2, 7:11 PM ET·0000834237-22-005459
Insiders
10- Bailey Jeffrey AllenDirector, Chief Executive Officer
- Bramlage CharlesDirector
- Broadfin Capital, LLCDirector
- Broadfin Healthcare Master Fund LtdDirector
- BUTLER JAMES RDirector
- Coelho Mary TheresaSee Remarks
- Cukier HermDirector, Chief Executive Officer
- D'Alonzo ThomasDirector
- Davis Todd CDirector
- De Paolantonio Ernest RobertCFO and Secretary
Tickers
No tickers on record
Addresses
business
4131 PARKLAKE AVENUE SUITE 225
RALEIGH, NC, 27612
mailing
4131 PARKLAKE AVENUE SUITE 225
RALEIGH, NC, 27612
Former Names
- MAS ACQUISITION XXIII CORP2000-04-18